Literature DB >> 20430925

Update in diffuse parenchymal lung disease 2009.

Oliver Eickelberg1, Moisés Selman.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20430925     DOI： 10.1164/rccm.201001-0124UP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  5 in total

1.  Protease-activated receptor-2 induces myofibroblast differentiation and tissue factor up-regulation during bleomycin-induced lung injury: potential role in pulmonary fibrosis.

Authors:  Keren Borensztajn; Paul Bresser; Chris van der Loos; Ilze Bot; Bernt van den Blink; Michael A den Bakker; Joost Daalhuisen; Angelique P Groot; Maikel P Peppelenbosch; Jan H von der Thüsen; C Arnold Spek
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

2.  Macrophage-derived biomarkers of idiopathic pulmonary fibrosis.

Authors:  E Bargagli; A Prasse; C Olivieri; J Muller-Quernheim; P Rottoli
Journal:  Pulm Med       Date:  2010-11-29

Review 3.  Myofibroblasts and lung fibrosis induced by carbon nanotube exposure.

Authors:  Jie Dong; Qiang Ma
Journal:  Part Fibre Toxicol       Date:  2016-11-04       Impact factor: 9.400

4.  Human alveolar epithelial cells type II are capable of TGFβ-dependent epithelial-mesenchymal-transition and collagen-synthesis.

Authors:  Torsten Goldmann; Gernot Zissel; Henrik Watz; Daniel Drömann; Martin Reck; Christian Kugler; Klaus F Rabe; Sebastian Marwitz
Journal:  Respir Res       Date:  2018-07-24

5.  Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis.

Authors:  R S Baliga; C J Scotton; S L Trinder; R C Chambers; R J MacAllister; A J Hobbs
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.